A retrospective review of the metabolic syndrome in women diagnosed with breast cancer and correlation with estrogen receptor

Breast Cancer Research and Treatment

Volumn 131, Issue 1, 2012, Pages 325-331

  Colonna, Sarah V ^a   Douglas Case, L ^b   Lawrence, Julia A ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

Breast cancer; Comorbidities; Metabolic syndrome

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AFRICAN AMERICAN; AGE; AGED; BREAST CANCER; CANCER LOCALIZATION; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OBESITY; PATIENT ASSESSMENT; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; REVIEW;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; BREAST NEOPLASMS; COMORBIDITY; FEMALE; HUMANS; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; RECEPTORS, ESTROGEN; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84856220772     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1790-x     Document Type: Review

References (40)

1. M Protani M Coory JH Martin 2010 Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis Breast Cancer Res Treat 123 627 635 10.1007/s10549-010-0990-0 20571870 10.1007/s10549-010-0990-0
2. GC Kabat M Kim RT Chlebowski J Khandekar MG Ko A McTiernan ML Neuhouser DR Parker JM Shikany ML Stefanick CA Thomson TE Rohan 2009 A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer Cancer Epidemiol Biomark Prev 18 2046 2053 10.1158/1055-9965.EPI-09-0235 10.1158/1055-9965.EPI-09-0235 1:CAS:528:DC%2BD1MXosFWjsrs%3D
3. G Ursin MP Longnecker RW Haile S Greenland 1995 A meta-analysis of body mass index and risk of premenopausal breast cancer Epidemiology 6 137 141 7742399 10.1097/00001648-199503000-00009 1:STN:280:DyaK2M3mtVyqug%3D%3D
4. I Capasso E Esposito F Pentimalli A Crispo M Montella M Grimaldi MM De E Cavalcanti M D'Aiuto A Fucito G Frasci N Maurea G Esposito T Pedicini A Vecchione G D'Aiuto A Giordano 2011 Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience Cancer Biol Ther 10 1240 1243 10.4161/cbt.10.12.13473 20935521
5. LA Healy AM Ryan P Carroll D Ennis V Crowley T Boyle MJ Kennedy E Connolly JV Reynolds 2010 Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer Clin Oncol (R Coll Radiol) 22 281 288 10.1016/j.clon.2010.02.001 10.1016/j.clon.2010.02.001 1:STN:280:DC%2BC3c3nt1Gjug%3D%3D
6. JA Laukkanen DE Laaksonen L Niskanen E Pukkala A Hakkarainen JT Salonen 2004 Metabolic syndrome and the risk of prostate cancer in Finnish men: a population-based study Cancer Epidemiol Biomark Prev 13 1646 1650 1:CAS:528:DC%2BD2cXotFWnsrw%3D (Pubitemid 39331887)
7. A Jemal R Siegel J Xu E Ward 2010 Cancer statistics, 2010 CA Cancer J Clin 60 277 300 10.3322/caac.20073 20610543 10.3322/caac.20073
8. LA Carey CM Perou CA Livasy LG Dressler D Cowan K Conway G Karaca MA Troester CK Tse S Edmiston SL Deming J Geradts MC Cheang TO Nielsen PG Moorman HS Earp RC Millikan 2006 Race, breast cancer subtypes, and survival in the Carolina breast cancer study JAMA 295 2492 2502 10.1001/jama.295.21.2492 16757721 10.1001/jama.295.21.2492 1:CAS:528:DC%2BD28XlsV2rtLw%3D (Pubitemid 43854964)
9. LK Dunnwald MA Rossing CI Li 2007 Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients Breast Cancer Res 9 R6 1 10 10.1186/bcr1639 (Pubitemid 350215155)
10. RM Elledge GM Clark GC Chamness CK Osborne 1994 Tumor biologic factors and breast cancer prognosis among white, hispanic, and black women in the United States J Natl Cancer Inst 86 705 712 10.1093/jnci/86.9.705 7908990 10.1093/jnci/86.9.705 1:STN:280:DyaK2c3htVGmsA%3D%3D (Pubitemid 24138977)
11. Gapstur SM, Dupuis J, Gann P, Collila S, Winchester DP (1996) Hormone receptor status of breast tumors in black, hispanic, and non-hispanic white women: an analysis of 13,239 cases. Cancer 77:1465-1471. doi: 10.1002/(SICI)1097-0142(19960415)77:8<1465::AID-CNCR7>3.0.CO;2-B (Pubitemid 26105381)
12. CL Ogden MD Carroll LR Curtin MA McDowell CJ Tabak KM Flegal 2006 Prevalence of overweight and obesity in the United States, 1999-2004 JAMA 295 1549 1555 10.1001/jama.295.13.1549 16595758 10.1001/jama.295.13.1549 1:CAS:528:DC%2BD28Xjt12itrk%3D
13. Y Wang MA Beydoun 2007 The obesity epidemic in the United States-gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis Epidemiol Rev 29 6 28 10.1093/epirev/mxm007 17510091 10.1093/epirev/mxm007 1:CAS:528:DC%2BD1cXhtFSntb3L (Pubitemid 47229643)
14. ES Ford WH Giles WH Dietz 2002 Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey JAMA 287 356 359 10.1001/jama.287.3.356 11790215 10.1001/jama.287.3.356 (Pubitemid 34251969)
15. KG Alberti RH Eckel SM Grundy PZ Zimmet JI Cleeman KA Donato JC Fruchart WP James CM Loria SC Smith Jr. 2009 Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 120 1640 1645 10.1161/CIRCULATIONAHA.109.192644 19805654 10.1161/CIRCULATIONAHA.109. 192644 1:CAS:528:DC%2BD1MXht1OrtrrK
16. Group TEHaBCC T Key P Appleyby G Reeves A Roddam 2010 Insulin-like growth factor 1 (IGF1) IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies Lancet Oncol 11 530 542 10.1016/S1470-2045(10)70095-4 20472501 10.1016/S1470-2045(10)70095-4
17. PH Lahmann K Hoffmann N Allen CH van Gils KT Khaw B Tehard F Berrino A Tjonneland J Bigaard A Olsen K Overvad F Clavel-Chapelon G Nagel H Boeing D Trichopoulos G Economou G Bellos D Palli R Tumino S Panico C Sacerdote V Krogh PH Peeters HB Bueno-de-Mesquita E Lund E Ardanaz P Amiano G Pera Jr. Quiros C Martinez MJ Tormo E Wirfalt G Berglund G Hallmans TJ Key G Reeves S Bingham T Norat C Biessy R Kaaks E Riboli 2004 Body size and breast cancer risk: findings from the European prospective investigation into cancer and nutrition (EPIC) Int J Cancer 111 762 771 10.1002/ijc.20315 15252848 10.1002/ijc.20315 1:CAS:528:DC%2BD2cXmvVenu7w%3D (Pubitemid 39062901)
18. M Sarkissyan Y Wu JV Vadgama 2011 Obesity is associated with breast cancer in African-American women but not hispanic women in South Los Angeles Cancer 117 3814 3823 10.1002/cncr.25956 21305540 10.1002/cncr.25956
19. XR Yang J Chang-Claude EL Goode FJ Couch H Nevanlinna RL Milne M Gaudet MK Schmidt A Broeks A Cox PA Fasching R Hein AB Spurdle F Blows K Driver D Flesch-Janys J Heinz P Sinn A Vrieling T Heikkinen K Aittomaki P Heikkila C Blomqvist J Lissowska B Peplonska S Chanock J Figueroa L Brinton P Hall K Czene K Humphreys H Darabi J Liu LJ Van 't Veer FE van Leeuwen IL Andrulis G Glendon JA Knight AM Mulligan FP O'Malley N Weerasooriya EM John MW Beckmann A Hartmann SB Weihbrecht DL Wachter SM Jud CR Loehberg L Baglietto DR English GG Giles CA McLean G Severi D Lambrechts T Vandorpe C Weltens R Paridaens A Smeets P Neven H Wildiers X Wang JE Olson V Cafourek Z Fredericksen M Kosel C Vachon HE Cramp D Connley SS Cross SP Balasubramanian MW Reed T Dork M Bremer A Meyer JH Karstens A Ay TW Park-Simon P Hillemanns JI Arias Perez RP Menendez P Zamora J Benitez YD Ko HP Fischer U Hamann B Pesch T Bruning C Justenhoven H Brauch DM Eccles WJ Tapper SM Gerty EJ Sawyer IP Tomlinson A Jones M Kerin N Miller N McInerney H Anton-Culver A Ziogas CY Shen CN Hsiung PE Wu SL Yang JC Yu ST Chen GC Hsu CA Haiman BE Henderson ML Le LN Kolonel A Lindblom S Margolin A Jakubowska J Lubinski T Huzarski T Byrski B Gorski J Gronwald MJ Hooning A Hollestelle AM van den Ouweland A Jager M Kriege MM Tilanus-Linthorst M Collee S Wang-Gohrke K Pylkas A Jukkola-Vuorinen K Mononen M Grip P Hirvikoski R Winqvist A Mannermaa VM Kosma J Kauppinen V Kataja P Auvinen Y Soini R Sironen SE Bojesen DD Orsted D Kaur-Knudsen H Flyger BG Nordestgaard H Holland G Chenevix-Trench S Manoukian M Barile P Radice SE Hankinson DJ Hunter R Tamimi S Sangrajrang P Brennan J McKay F Odefrey V Gaborieau P Devilee PE Huijts RA Tollenaar C Seynaeve GS Dite C Apicella JL Hopper F Hammet H Tsimiklis LD Smith MC Southey MK Humphreys D Easton P Pharoah ME Sherman M Garcia-Closas 2011 Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies J Natl Cancer Inst 103 250 263 10.1093/jnci/djq526 21191117 10.1093/jnci/djq526
20. C Pichard G Plu-Bureau N-E Castro A Gompel 2008 Insulin resistance, obesity and breast cancer risk Maturitas 60 19 30 10.1016/j.maturitas.2008.03. 002 18485631 10.1016/j.maturitas.2008.03.002 1:CAS:528:DC%2BD1cXnvVKitrk%3D
21. C Agnoli F Berrino CA Abagnato P Muti S Panico P Crosignani V Krogh 2010 Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study Nutr Metab Cardiovasc Dis 20 41 48 10.1016/j.numecd.2009.02.006 19361966 10.1016/j.numecd.2009.02.006 1:STN:280:DC%2BC3c7gsFylug%3D%3D
22. B Maiti MN Kundranda TP Spiro HA Daw 2010 The association of metabolic syndrome with triple-negative breast cancer Breast Cancer Res Treat 121 479 483 10.1007/s10549-009-0591-y 19851862 10.1007/s10549-009-0591-y 1:STN:280:DC%2BC3czkvVOkug%3D%3D
23. SM Grundy JI Cleeman SR Daniels KA Donato RH Eckel BA Franklin DJ Gordon RM Krauss PJ Savage SC Smith Jr. JA Spertus F Costa 2005 Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary Cardiol Rev 13 322 327 1097/01.crd.0000380842.14048.7e 16708441 (Pubitemid 41579599)
24. P Strazzullo A Barbato A Siani FP Cappuccio M Versiero P Schiattarella O Russo S Avallone VE della Farinaro 2008 Diagnostic criteria for metabolic syndrome: a comparative analysis in an unselected sample of adult male population Metabolism 57 355 361 10.1016/j.metabol.2007.10.010 18249207 10.1016/j.metabol.2007.10.010 1:CAS:528:DC%2BD1cXhsVSitLo%3D (Pubitemid 351178724)
25. T Sorlie 2009 Introducing molecular subtyping of breast cancer into the clinic? J Clin Oncol 27 1153 1154 10.1200/JCO.2008.20.6276 19204193 10.1200/JCO.2008.20.6276
26. TO Nielsen FD Hsu K Jensen M Cheang G Karaca Z Hu T Hernandez-Boussard C Livasy D Cowan L Dressler LA Akslen J Ragaz AM Gown CB Gilks M van de Rijn CM Perou 2004 Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma Clin Cancer Res 10 5367 5374 10.1158/1078-0432.CCR-04-0220 15328174 10.1158/1078-0432.CCR-04-0220 1:CAS:528:DC%2BD2cXmvFSlt7k%3D (Pubitemid 39100473)
27. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625-1638. http://www.nejm.org/doi/full/10.1056/ NEJMoa021423 (Pubitemid 36459468)
28. AE de W McCaskill-Stevens P Francis E Quinaux JP Crown M Vicente R Giuliani B Nordenskjold J Gutierez M Andersson MM Vila R Jakesz J Demol J Dewar A Santoro A Lluch S Olsen RD Gelber LA Di M Piccart-Gebhart 2010 The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial Breast Cancer Res Treat 119 145 153 10.1007/s10549-009-0512-0 10.1007/s10549-009-0512-0
29. JJ Dignam K Wieand KA Johnson P Raich SJ Anderson C Somkin DL Wickerham 2006 Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer Breast Cancer Res Treat 97 245 254 10.1007/s10549-005-9118-3 16331345 10.1007/s10549-005-9118-3 (Pubitemid 43948218)
30. M Ewertz MB Jensen KA Gunnarsdottir I Hojris EH Jakobsen D Nielsen LE Stenbygaard UB Tange S Cold 2011 Effect of obesity on prognosis after early-stage breast cancer J Clin Oncol 29 25 31 10.1200/JCO.2010.29.7614 21115856 10.1200/JCO.2010.29.7614
31. C Duggan ML Irwin L Xiao KD Henderson AW Smith RN Baumgartner KB Baumgartner L Bernstein R Ballard-Barbash A McTiernan 2011 Associations of insulin resistance and adiponectin with mortality in women with breast cancer J Clin Oncol 29 32 39 10.1200/JCO.2009.26.4473 21115858 10.1200/JCO.2009.26.4473 1:CAS:528:DC%2BC3MXhsFKhsLY%3D
32. AM Lorincz S Sukumar 2006 Molecular links between obesity and breast cancer Endocr Relat Cancer 13 279 292 10.1677/erc.1.00729 16728564 10.1677/erc.1.00729 1:CAS:528:DC%2BD28XntF2mt7c%3D (Pubitemid 43886659)
33. DP Rose SM Haffner J Baillargeon 2007 Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women Endocr Rev 28 763 777 10.1210/er.2006-0019 17981890 10.1210/er.2006-0019 1:CAS:528: DC%2BD1cXhtVKlsro%3D (Pubitemid 350294295)
34. T Kadowaki T Yamauchi 2005 Adiponectin and adiponectin receptors Endocr Rev 26 439 451 10.1210/er.2005-0005 15897298 10.1210/er.2005-0005 1:CAS:528:DC%2BD2MXltVWru7c%3D (Pubitemid 40686653)
35. Y Miyoshi T Funahashi S Kihara T Taguchi Y Tamaki Y Matsuzawa S Noguchi 2003 Association of serum adiponectin levels with breast cancer risk Clin Cancer Res 9 5699 5704 14654554 1:CAS:528:DC%2BD3sXpsVeju74%3D (Pubitemid 37499493)
36. JB Meigs PW Wilson DM Nathan RB D'Agostino Sr K Williams SM Haffner 2003 Prevalence and characteristics of the metabolic syndrome in the San Antonio heart and Framingham offspring studies Diabetes 52 2160 2167 10.2337/diabetes.52.8.2160 12882936 10.2337/diabetes.52.8.2160 1:CAS:528:DC%2BD3sXlvFCgtbk%3D (Pubitemid 36919812)
37. TM Welzel BI Graubard S Zeuzem HB El-Serag JA Davila KA McGlynn 2011 Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-medicare database Hepatology 54 463 471 10.1002/hep.24397 21538440 10.1002/hep.24397
38. EA Perez VJ Suman NE Davidson GW Sledge PA Kaufman CA Hudis S Martino Jr. Gralow SR Dakhil JN Ingle EP Winer KA Gelmon BJ Gersh AS Jaffe RJ Rodeheffer 2008 Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial J Clin Oncol 26 1231 1238 10.1200/JCO.2007.13.5467 18250349 10.1200/JCO.2007.13.5467 1:CAS:528: DC%2BD1cXksVehu7s%3D
39. Scripture CD, Figg WD, Sparreboom A (2006) Peripheral neuropathy induced by paclitaxel: recent insights and future perspectives. Curr Neuropharmacol 4:165-172 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430667/?tool=pubmed
40. CN Klabunde NL Keating AL Potosky A Ambs Y He MC Hornbrook PA Ganz 2011 A population-based assessment of specialty physician involvement in cancer clinical trials J Natl Cancer Inst 103 384 397 10.1093/jnci/djq549 21317382 10.1093/jnci/djq549